Acquired resistance to osimertinib in advanced lung cancer: A case report

被引：0
|
作者：
Xu, Jiayi [1 ,2 ]
Xu, Zikai [1 ]
Hong, Jianwei [2 ,3 ]
Zhou, Xiaoyu [1 ]
机构：
[1] Nantong Univ, Dept Resp & Crit Care Med, Affiliated Hosp, 20 Xisi Rd, Nantong 226001, Peoples R China
[2] Nantong Univ, Med Sch, Nantong 226001, Peoples R China
[3] Nantong Univ, Dept Gastroenterol, Affiliated Hosp, Nantong 226001, Peoples R China
来源：
ASIAN JOURNAL OF SURGERY | 2024年 / 47卷 / 08期
关键词：
D O I：
10.1016/j.asjsur.2024.04.116
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：3763 / 3764
页数：2
相关论文
共 50 条
  • [41] Acquired resistance to osimertinib in patients with non-small-cell lung cancer: mechanisms and clinical outcomes
    Mu, Yuxin
    Hao, Xuezhi
    Xing, Puyuan
    Hu, Xingsheng
    Wang, Yan
    Li, Teng
    Zhang, Jinyao
    Xu, Ziyi
    Li, Junling
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (09) : 2427 - 2433
  • [42] Acquired rare recurrent EGFR mutations as mechanisms of resistance to Osimertinib in lung cancer and in silico structural modelling
    Lin, Lin
    Lu, Qiang
    Cao, Ran
    Ou, Qiuxiang
    Ma, Yutong
    Bao, Hua
    Wu, Xue
    Shao, Yang
    Wang, Zhaoxia
    Shen, Bo
    AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (11): : 4005 - +
  • [43] The Combined Therapy of Cabozantinib, Crizotinib, and Osimertinib in a Lung Cancer Patient with Acquired MET Amplification and Resistance Mutations
    Jori, Balazs
    Voessing, Christine
    Pirngruber, Judith
    Willing, Eva Maria
    Arndt, Kathrin
    Falk, Markus
    Tiemann, Markus
    Heukamp, Lukas C.
    Hoffknecht, Petra
    CURRENT ONCOLOGY, 2023, 30 (10) : 8805 - 8814
  • [44] OSIMERTINIB-INDUCED VENOUS THROMBOEMBOLISM IN LUNG CANCER? A CHALLENGING CASE REPORT
    Leopizzi, T.
    Fioretti, A.
    Catino, A.
    Oliva, S.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0C) : C84 - C84
  • [45] OsimertinibAcquired resistance to osimertinib leading to transformation of lung adenocarcinoma to small cell lung carcinoma: case report
    Reactions Weekly, 2017, 1654 (1) : 265 - 265
  • [46] Acquired Resistance in Lung Cancer
    Tulpule, Asmin
    Bivona, Trever G.
    ANNUAL REVIEW OF CANCER BIOLOGY, VOL 4, 2020, 4 : 279 - 297
  • [47] Acquired resistance in lung cancer
    Pamela Feliciano
    Nature Genetics, 2012, 44 (3) : 241 - 241
  • [48] Acquired resistance to osimertinib in patients with non-small-cell lung cancer: mechanisms and clinical outcomes
    Yuxin Mu
    Xuezhi Hao
    Puyuan Xing
    Xingsheng Hu
    Yan Wang
    Teng Li
    Jinyao Zhang
    Ziyi Xu
    Junling Li
    Journal of Cancer Research and Clinical Oncology, 2020, 146 : 2427 - 2433
  • [49] CircMYBL1 suppressed acquired resistance to osimertinib in non-small-cell lung cancer
    Li, Yaji
    Wang, Nan
    Huang, Yutang
    He, Shuai
    Bao, Meihua
    Wen, Chunjie
    Wu, Lanxiang
    CANCER GENETICS, 2024, 284-285 : 34 - 42
  • [50] Osimertinib as Salvage Therapy in Advanced Non-Small Cell Lung Cancer After Aumolertinib Resistance With T790M Mutation: A Case Report
    Tang, Yongtong
    Xu, Jilan
    Chen, Qingle
    Lu, Jianping
    Ren, Li
    Lan, Taihe
    Liao, Taihua
    Chen, Xiaoling
    Yi, Hui
    Zhang, Jun
    Huang, Jie
    CLINICAL CASE REPORTS, 2025, 13 (02):
12345